Articles with public access mandates - Zhuoer XieLearn more
Not available anywhere: 1
Updates in classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): a state-of-the-art report on behalf of the International …
M Stahl, JP Bewersdorf, Z Xie, MG Della Porta, R Komrokji, ML Xu, ...
Blood Reviews, 101128, 2023
Mandates: US National Institutes of Health, AIRC Foundation for Cancer Research in Italy
Available somewhere: 24
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ...
Annals of oncology 32 (6), 787-800, 2021
Mandates: US National Institutes of Health, Fonds de recherche du Québec - Santé
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
Mandates: US National Institutes of Health, US Assistant Secretary for Preparedness …
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study
DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ...
Cancer discovery 10 (10), 1514-1527, 2020
Mandates: US National Institutes of Health
Spectrum of clonal hematopoiesis in VEXAS syndrome
F Gutierrez-Rodrigues, Y Kusne, J Fernandez, T Lasho, R Shalhoub, ...
Blood, The Journal of the American Society of Hematology 142 (3), 244-259, 2023
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo, US National Institutes …
Racial disparities in COVID-19 outcomes among black and white patients with cancer
J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ...
JAMA network open 5 (3), e224304-e224304, 2022
Mandates: US National Institutes of Health
Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19
AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ...
JAMA network open 4 (11), e2134330-e2134330, 2021
Mandates: US National Institutes of Health
A combination of indoor localization and wearable sensor–based physical activity recognition to assess older patients undergoing subacute rehabilitation: Baseline study results
R Ramezani, W Zhang, Z Xie, J Shen, D Elashoff, P Roberts, A Stanton, ...
JMIR mHealth and uHealth 7 (7), e14090, 2019
Mandates: US National Institutes of Health
Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19
Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ...
JAMA oncology 9 (1), 128-134, 2023
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Management of acute myeloid leukemia (AML) in older patients
M Abdallah, Z Xie, A Ready, D Manogna, JH Mendler, KP Loh
Current oncology reports 22, 1-14, 2020
Mandates: US National Institutes of Health
Risk estimation, anxiety, and breast cancer worry in women at risk for breast cancer: A single‐arm trial of personalized risk communication
Z Xie, N Wenger, AL Stanton, K Sepucha, C Kaplan, L Madlensky, ...
Psycho‐oncology 28 (11), 2226-2232, 2019
Mandates: US National Institutes of Health
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
AM Zeidan, JP Bewersdorf, R Buckstein, MA Sekeres, DP Steensma, ...
Leukemia 36 (12), 2939-2946, 2022
Mandates: US National Institutes of Health
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the …
JP Bewersdorf, Z Xie, R Bejar, U Borate, J Boultwood, AM Brunner, ...
Blood Reviews 60, 101072, 2023
Mandates: US National Institutes of Health, AIRC Foundation for Cancer Research in Italy
CHIPing away the progression potential of CHIP: a new reality in the making
Z Xie, AM Zeidan
Blood Reviews 58, 101001, 2023
Mandates: US National Institutes of Health
Clonal hematopoiesis of indeterminate potential is associated with coronary microvascular dysfunction in early nonobstructive coronary artery disease
N Akhiyat, T Lasho, M Ganji, T Toya, CX Shi, X Chen, E Braggio, A Ahmad, ...
Arteriosclerosis, thrombosis, and vascular biology 43 (5), 774-783, 2023
Mandates: US National Institutes of Health
Electronic video consent to power precision health research: a pilot cohort study
A Naeim, S Dry, D Elashoff, Z Xie, A Petruse, C Magyar, L Johansen, ...
JMIR formative research 5 (9), e29123, 2021
Mandates: US National Institutes of Health
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
M Stahl, O Abdel-Wahab, AH Wei, MR Savona, ML Xu, Z Xie, J Taylor, ...
Blood advances 7 (12), 2709-2714, 2023
Mandates: US National Institutes of Health
Assessment of regional variability in COVID-19 outcomes among patients with cancer in the United States
JE Hawley, T Sun, DD Chism, N Duma, JC Fu, NTN Gatson, S Mishra, ...
JAMA network open 5 (1), e2142046-e2142046, 2022
Mandates: US National Institutes of Health
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium …
M Stahl, JP Bewersdorf, Z Xie, MGD Porta, R Komrokji, X Mina L, ...
Blood Reviews 62, 0-0, 2023
Mandates: US National Institutes of Health, AIRC Foundation for Cancer Research in Italy
Publication and funding information is determined automatically by a computer program